453 related articles for article (PubMed ID: 12662131)
21. Drug mechanisms in anxiety.
Bourin M; Hascoët M
Curr Opin Investig Drugs; 2001 Feb; 2(2):259-65. PubMed ID: 11816841
[TBL] [Abstract][Full Text] [Related]
22. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.
Krystal JH; Staley J; Mason G; Petrakis IL; Kaufman J; Harris RA; Gelernter J; Lappalainen J
Arch Gen Psychiatry; 2006 Sep; 63(9):957-68. PubMed ID: 16952998
[TBL] [Abstract][Full Text] [Related]
23. [The neurobiology of anxiety: current assessment and perspectives].
Tobeña Pallarés A
Med Clin (Barc); 1988 May; 90(20):824-30. PubMed ID: 2901514
[No Abstract] [Full Text] [Related]
24. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.
Zwanzger P; Rupprecht R
J Psychiatry Neurosci; 2005 May; 30(3):167-75. PubMed ID: 15944741
[TBL] [Abstract][Full Text] [Related]
25. GABA systems, benzodiazepines, and substance dependence.
Malcolm RJ
J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
[TBL] [Abstract][Full Text] [Related]
26. GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?
Bailey JE; Nutt DJ
Pharmacol Biochem Behav; 2008 Jul; 90(1):51-7. PubMed ID: 18485466
[TBL] [Abstract][Full Text] [Related]
27. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
28. Two animal models of anxiety--different sensitivity for anxiolytic action of GABAA receptor complex ligands.
Nazar M; Płaznik A; Jessa M
Acta Physiol Hung; 1996; 84(4):437-9. PubMed ID: 9328625
[No Abstract] [Full Text] [Related]
29. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes.
Cooper SJ
Appetite; 2005 Apr; 44(2):133-50. PubMed ID: 15808888
[TBL] [Abstract][Full Text] [Related]
30. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
[TBL] [Abstract][Full Text] [Related]
31. Neural and molecular mechanisms in anxiety.
Wolkowitz OM; Paul SM
Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
[TBL] [Abstract][Full Text] [Related]
32. [The benzodiazepine receptor: the enigma of the endogenous ligand].
Pélissolo A
Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic profiles.
Gershon S; Eison AS
J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
[TBL] [Abstract][Full Text] [Related]
34. [Advances in clinical treatment of anxiety disorders].
Yu Z; Yian H
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):116-9. PubMed ID: 1354152
[No Abstract] [Full Text] [Related]
35. [Neurobiological approach to anxiety].
Boyer P
Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():43-6. PubMed ID: 2889436
[No Abstract] [Full Text] [Related]
36. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
[TBL] [Abstract][Full Text] [Related]
37. Designing new treatments for depression and anxiety.
Chen Z; Yang J; Tobak A
IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
[TBL] [Abstract][Full Text] [Related]
38. [New problems in GABAergic pharmacology of anxiety].
Kaluev AV
Eksp Klin Farmakol; 1997; 60(5):3-7. PubMed ID: 9483395
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
[TBL] [Abstract][Full Text] [Related]
40. [Etifoxine: a new look at the GABA receptor and anxiety].
Spadone C; Glikman M
Encephale; 2008 Apr; 34 Spec No 1():1-11. PubMed ID: 18826172
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
